POET Technologies Soars On Lumilens AI Deal And $400M Raise

POET Technologies Inc. surged as a major photonics partnership spurred optimism, and stocks have been trading up by 8.18 percent.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading POET

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways Traders Need To Know

Strategic partnership with Lumilens includes a $50M initial order for POET’s Electrical-Optical Interposer engines, with potential to exceed $500M over five years in frontier AI infrastructure.
The Lumilens agreement, plus performance-based warrants, launched POET’s stock more than 33%–39% on heavy volume as traders repriced the AI photonics story.
A US$400M non-brokered registered direct deal with a single institutional buyer at about $21 per share-plus-warrant funds a major capacity build-out despite dilution.
Proceeds target roughly a 10x lift in POET’s manufacturing capacity, faster R&D and hiring, light-source acceleration, potential M&A, and working capital into 2027.
Veteran chip operator Dr. Sandeep Kumar joins POET as COO to scale Malaysia manufacturing for high-volume optical engines and light-source products.

Live Update At 12:33:06 EDT: On Monday, June 08, 2026 POET Technologies Inc. stock [NASDAQ: POET] is trending up by 8.18%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

POET Technologies is trading like a high‑beta AI hardware bet, not a mature cash machine. The chart tells the story. After spiking to $20.57 on 2026/05/14, POET has spent the past few weeks giving back a chunk of those gains, closing at $12.835 on 2026/06/08. That’s a sharp round trip from the $18–$20 zone down into the low teens, with several wide‑range days between $11.8 and $15.9. Traders are clearly still price‑discovering this story.

Intraday, the 5‑minute tape shows POET grinding higher off a $11.77 open toward the $12.90 area, with tight, liquid candles and steady bids. That’s controlled action, not a panic flush.

More Breaking News

Fundamentals remain early‑stage. POET booked just over $1.0M in revenue in the latest quarter and a net loss of about $12.3M. Margins are deeply negative and returns on assets and equity are both worse than -40%, signaling a company still in heavy build mode. Yet the balance sheet is strong: minimal debt, a huge current ratio above 30, and over $429M in cash and equivalents after the raise. For traders, POET is a classic “story plus cash” AI infrastructure name, with the stock swinging on headlines and expectations rather than earnings power today.

Why Traders Are Watching POET’s AI Photonics Pivot

POET Technologies has flipped the script from “interesting tech” to “booked pipeline” almost overnight. The core catalyst is the Lumilens partnership. POET’s Electrical‑Optical Interposer platform just landed a strategic supply and technology deal aimed squarely at frontier AI infrastructure, including a $50M initial purchase order. Management and Lumilens frame that as the starting line, with potential to scale above $500M across five years if performance milestones are met.

The market didn’t wait to celebrate. On 2026/05/14, news of the Lumilens agreement sent POET stock ripping more than 33%–39% on heavy volume. That kind of extension move tells you traders saw this as a step‑change event, not a routine design win. It’s the first time POET has real multi‑year revenue visibility in AI and data center optics rather than just demos and slide decks.

At the same time, POET reinforced the story with fresh leadership. The company hired Dr. Sandeep Kumar, a long‑tenured Silicon Labs operator, as chief operating officer. His first big task: build out high‑volume manufacturing in Malaysia for POET’s optical engines and light‑source products. That matters because a $500M‑plus Lumilens pipeline is only as good as POET’s ability to ship clean, consistent product at scale. POET’s Q1 2026 print still showed “immaterial” revenue and a sizable loss, but the quarter marked a strategic inflection point — Lumilens, new collaborations with LITEON and Lessengers, and a plan to redomicile to the U.S. to sit closer to AI and data center customers. Traders are betting on that pivot, and the chart’s volatility reflects the tug‑of‑war between future promise and current red ink.

Conclusion

The second big swing factor for POET Technologies is money. Right after the Lumilens spike, POET locked in a US$400M registered direct offering with a single institutional investor. The deal came at roughly $21 per share‑plus‑warrant, a small premium to the prior close, and included three‑year warrants on 19,047,620 shares at about a 25% premium strike of $26.15. That is serious institutional conviction in a small‑revenue name.

Traders hate dilution, and POET’s stock did slip about 10% on the offering headlines. But the flip side is powerful: a roughly 10x planned capacity expansion, accelerated hiring and facilities build‑out, more R&D, light‑source business acceleration, and potential M&A or partnerships. With more than $400M now earmarked for AI and data center photonics, POET has the cash to try to turn the Lumilens order and its newer collaborations into a real, scaled business.

For active traders, POET is now a classic high‑volatility, catalyst‑driven chart. The bull case leans on the Lumilens path to $500M‑plus, deep cash reserves, and seasoned operations leadership. The bear case points to heavy losses, rich valuation on tiny current sales, and warrant overhang. As Tim Sykes likes to remind traders, “The market doesn’t care about your opinion, only your discipline — cut losses quickly, trade the pattern, not the story.” As Tim Bohen, lead trainer with StocksToTrade says, “The best way to learn is by tracking trades, wins, losses, and lessons learned. Every trade has something to teach.” With POET, that means respecting the wild swings, tracking each new execution milestone, and remembering this is educational and research content — not advice to buy or sell any stock.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!